Last reviewed · How we verify
Pyridinylmethyl-14C-labeled isavuconazonium sulfate — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Pyridinylmethyl-14C-labeled isavuconazonium sulfate (Pyridinylmethyl-14C-labeled isavuconazonium sulfate) — Astellas Pharma Global Development, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pyridinylmethyl-14C-labeled isavuconazonium sulfate TARGET | Pyridinylmethyl-14C-labeled isavuconazonium sulfate | Astellas Pharma Global Development, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pyridinylmethyl-14C-labeled isavuconazonium sulfate CI watch — RSS
- Pyridinylmethyl-14C-labeled isavuconazonium sulfate CI watch — Atom
- Pyridinylmethyl-14C-labeled isavuconazonium sulfate CI watch — JSON
- Pyridinylmethyl-14C-labeled isavuconazonium sulfate alone — RSS
Cite this brief
Drug Landscape (2026). Pyridinylmethyl-14C-labeled isavuconazonium sulfate — Competitive Intelligence Brief. https://druglandscape.com/ci/pyridinylmethyl-14c-labeled-isavuconazonium-sulfate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab